Friday, 18 January 2013

Teva's citizen petition to the FDA on behalf of MSers in the USA

In response to an email request about not being able to access the following letter online. I have downloaded it for you and embedded the full letter for you to read.

The following is the result of our survey in relation to this letter:

Other posts in relation to Teva on this blog:

17 Jan 2013
As you know TEVA has requested that licensing of new drugs are delayed until the safety of any new drug is adequately reviewed, with an effect of trying to delay BG-12 and Lemtrada, although they are clearly aiming at the ...
13 Jan 2013
"Teva,the producer of glatiramer acetate, has asked the FDA not to approve BG-12, citing safety concerns. Teva filed a citizen's petition requesting that the FDA refrain from approving any new drug for the treatment of MS until ...
07 Apr 2012
Teva Pharmaceutical Industries Ltd. (TEVA) sued Synthon BV for infringing seven patents in planning to sell a generic version of the multiple sclerosis drug Copaxone before Teva's patents expire. Teva, based in Petach Tikva, ...
04 Nov 2011
Laquinimod News. After the phase 3 results (Allegro and Bravo studies) Teva's CEO Shlomo Yanai made the following statement concerning laquinimod: “Teva has held a meeting with the Food and Drug Administration (FDA) ...


  1. Rumour has it that the Teva employee behind this petition is about to be an ex-Teva employee!

    1. That's interesting. This has been a PR disaster for them. Where did you hear the rumour?

    2. Looks like J Michael Nicholas may be seeking alternative employment?

    3. I've noticed that people in MS pharma often circulate from one MS company to another but this guy has burnt his bridges at Biogen and I guess the others won't be in a hurry to hire.

  2. This comment has been removed by a blog administrator.

  3. I am sure it is orchestrated! welcome to my world.

    The scape goat will receive a fat check (i promise you, otherwise he will sue).

  4. This comment has been removed by a blog administrator.

  5. This comment has been removed by a blog administrator.


Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.